Understanding Juno Therapeutics Stock Symbol and Investment

Juno Therapeutics is a biopharmaceutical company that was acquired by Celgene in 2018, and its stock is now traded under the symbol JUNO.

The JUNO stock symbol was previously associated with Juno Therapeutics before the acquisition.

The acquisition by Celgene in 2018 led to the company's stock being traded under the new parent company's ticker symbol, CELG.

Investors who held Juno Therapeutics stock before the acquisition would have seen a change in their holdings' symbol, but the value of their investment remained intact.

The Juno share price has had its fair share of fluctuations. On March 1, 2018, the price opened at $86.66.

The price range on February 22, 2018, was between $86.57 and $86.75. This is a relatively small range compared to other days.

On February 21, 2018, the price dropped by 0.17, or 0.20%, to $84.98. This was the lowest closing price in the given period.

Here's a breakdown of the daily movements on February 20-22, 2018:

The price on March 1, 2018, opened at $86.66, and the price on March 3, 2018, opened at $86.80.